AUC Versus Peak-Trough Dosing of Vancomycin: Applying New Pharmacokinetic Paradigms to an Old Drug

被引:18
|
作者
Brown, Daniel L. [1 ]
Lalla, Christina D. [1 ]
Masselink, Andrew J. [1 ]
机构
[1] Palm Beach Atlantic Univ, Lloyd L Gregory Sch Pharm, W Palm Beach, FL 33416 USA
关键词
vancomycin; AUC; therapeutic drug monitoring; dosing nomogram; STAPHYLOCOCCUS-AUREUS INFECTIONS; MINIMUM INHIBITORY CONCENTRATION; POPULATION; OBESE; ACCURACY; NOMOGRAM; THERAPY; DOSAGE;
D O I
10.1097/FTD.0b013e31828b2a50
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To compare and contrast the pharmacokinetic/pharmacodynamic foundations of traditional peak-trough vancomycin dosing methods versus newer area under the curve (AUC) strategies. To propose a new AUC-based dosing chart for empirically determining an initial vancomycin dosing regimen designed to achieve a desired AUC(24) using the minimum inhibitory concentration (MIC), creatinine clearance (CrCl), and vancomycin clearance (Cl-Vanco).Review of vancomycin dosing: Peak-trough vancomycin dosing is designed to achieve a C-peak of 20-40 mg/L and a C-trough of 10-15 or 15-20 mg/L, depending on the severity of the infection and the nature of the pathogen. New treatment guidelines for vancomycin suggest that therapy should achieve an AUC(24)/MIC of 400. AUC-based vancomycin dosing derives the daily dose from Cl-Vanco, MIC, and the desired AUC(24)/MIC, without consideration of the patient's weight.New AUC dosing chart: A vancomycin dosing chart is proposed that estimates Cl-Vanco using the following formula developed by Matzke et al: Cl-Vanco in L/h = [(CrClmL/min x 0.689) + 3.66] x 0.06, which simplifies to (CrClmL/min x 0.41) + 0.22. Two levels of dosing are includedhigh dose (C-trough: 15-20 mg/L) and moderate dose (C-trough: 10-15 mg/L). Although the chart has not been validated clinically, it represents the product of standard dosing equations that are used to determine a starting dosing regimen based on well-established vancomycin pharmacokinetic parameters.Conclusions: An understanding of pharmacokinetic and pharmacodynamic principles, including the relevance of AUC in relation to MIC, enables clinicians to make the best use of vancomycin dosing options. The proposed dosing chart is pharmacokinetically valid but has yet to be applied clinically. It provides a foundation for further study of how clinicians can determine an optimal AUC-based starting vancomycin dosing regimen without having to derive Cl-Vanco or AUC(24).
引用
收藏
页码:443 / 449
页数:7
相关论文
共 11 条
  • [1] COMPARISON OF VANCOMYCIN AUC VERSUS TROUGH DOSING STRATEGIES ON NEPHROTOXICITY: A META-ANALYSIS
    Crovetto, Brynna
    Brunetti, Luigi
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 345 - 345
  • [2] Making the transition from trough based dosing of vancomycin to area under the curve (AUC) based dosing using Bayesian pharmacokinetic modelling software
    Tannous, E.
    Kewan, W.
    Selitzky, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 264 - 264
  • [3] Outpatient vancomycin therapy: Acute kidney injury in individualized AUC-based goal trough ranges versus traditional trough dosing
    Rees, Marissa R.
    Carr, Dustin R.
    Trienski, Tamara
    Buchanan, Carley
    White, Kara
    Bremmer, Derek N.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (03) : 706 - 710
  • [4] Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial
    Fatima Khalifa Al-Sulaiti
    Ahmed Mohamed Nader
    Mohamed Omar Saad
    Adila Shaukat
    Rakesh Parakadavathu
    Ahmed Elzubair
    Daoud Al-Badriyeh
    Hazem Elewa
    Ahmed Awaisu
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 639 - 652
  • [5] Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial
    Al-Sulaiti, Fatima Khalifa
    Nader, Ahmed Mohamed
    Saad, Mohamed Omar
    Shaukat, Adila
    Parakadavathu, Rakesh
    Elzubair, Ahmed
    Al-Badriyeh, Daoud
    Elewa, Hazem
    Awaisu, Ahmed
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (05) : 639 - 652
  • [6] Evaluating the Safety of Trough Versus Area Under the Curve (AUC)-Based Dosing Method of Vancomycin With Concomitant Piperacillin-Tazobactam
    Karas, Cassandra
    Manning, Kyle
    Childress, Darrell T.
    Covington, Elizabeth W.
    Manis, Melanie M.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (04) : 218 - 224
  • [7] Clinical and pharmacokinetic outcomes of peak-trough-based versus trough-only-based vancomycin therapeutic drug monitoring approaches: a pragmatic randomized controlled trial.
    Al-Sulaiti, Fatima Khalifa
    Nader, Ahmed Mohamed
    Saad, Mohamed
    Abdelaziz, Hani
    Shaukat, Adila
    Parakadavathu, Rakesh
    Elzubair, Ahmed
    Al-Badriyeh, Daoud
    Elewa, Hazem
    Awaisu, Ahmed
    PHARMACOTHERAPY, 2018, 38 (07): : E69 - E69
  • [8] Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost-benefit analysis
    Claus, Barbara O. M.
    De Smedt, Delphine
    De Cock, Pieter A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025, 80 (03) : 857 - 867
  • [9] USING AREA UNDER THE CURVE (AUC) TO MINIMUM INHIBITORY CONCENTRATION (MIC) ESTIMATIONS VERSUS TRADITIONAL TROUGH CONCENTRATIONS TO DETERMINE THE BEST DOSING REGIMEN FOR VANCOMYCIN IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Grisso, A. G.
    Di Pentima, C.
    Gillon, J.
    Kummick, J.
    Brown, R. F.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 316 - 316
  • [10] Methods of Therapeutic Drug Monitoring to Guide Vancomycin Dosing Regimens: Trough Concentration versus Ratio of Area Under the Curve to Minimum Inhibitory Concentration
    Du Sault, Ariane
    Parent, Marc
    Simard, Chantale
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (02): : 89 - 96